Literature DB >> 396577

The actions of prostaglandins I2 and E2 on arrhythmias produced by coronary occlusion in the rat and dog.

T L Au, G A Collins, C J Harvie, M J Walker.   

Abstract

Prostaglandins E2 and I2 were compared with known antiarrhythmics for their actions against arrhythmias produced by occlusion of the left anterior descending coronary artery in the anaesthetised rat while PGI2 was also examined in the dog. PGI2 in the dog suppressed early arrhythmias produced during occlusion but did not influence those produced by occlusion-release or those occurring 24 hours after a permanent occlusion; none of the A,B,C or D series prostaglandins tested markedly reduced 24 hour arrhythmias. In the rat PGE2 was antiarrhythmic against early occlusion arrhythmias (30 minutes occlusion) in a dose related manner (infusions of 1-4 microgram/kg/min) whereas PGI2 infusions potentiated the arrhythmogenic effect of occlusion. PGE2 was as effective an antiarrhythmic as 10mg/kg Org. 6001 which was more effective in this test situtation than dl-propranolol. No obvious mechanisms for the actions of PGE2 or PGI2 were apparent although both agents lowered blood pressure and reduced the size of the occluded zone produced by ligation.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 396577     DOI: 10.1016/0090-6980(79)90091-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  15 in total

1.  Prostacyclin as an endogenous anti-arrhythmic agent.

Authors:  U N Das
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

2.  Proceedings of the British Pharmacological Society. 5th-7th January, 1983. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

3.  Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat.

Authors:  R J Marshall; A W Muir; E Winslow
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

4.  The antiarrhythmic efficacy of intravenous anipamil against occlusion and reperfusion arrhythmias.

Authors:  B A MacLeod; M Moult; K M Saint; M J Walker
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

5.  Electrophysiological and antiarrhythmic actions of the kappa agonist PD 129290, and its R,R (+)-enantiomer, PD 129289.

Authors:  M K Pugsley; D A Saint; M P Penz; M J Walker
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Effects of prostacyclin analogue, OP-2507, on function and metabolism in the ischemic working rat heart.

Authors:  T Oguchi; S Kashimoto; T Nakamura; T Kumazawa
Journal:  J Anesth       Date:  1992-10       Impact factor: 2.078

7.  Development of a severe model of early coronary artery ligation-induced dysrhythmias in the anaesthetized rat.

Authors:  R J Marshall; A W Muir; E Winslow
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

8.  Effects of prostaglandin E2, propranolol and nitroglycerine with halothane, pethidine or pentobarbitone anaesthesia on arrhythmias and other responses to ligation of a coronary artery in rats.

Authors:  T L Au; G A Collins; B A Macleod; M J Walker
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

9.  Antiarrhythmic actions of verapamil against ischaemic arrhythmias in the rat.

Authors:  M J Curtis; B A MacLeod; M J Walker
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

10.  The effect of modification of sympathetic activity on responses to ligation of a coronary artery in the conscious rat.

Authors:  J H Botting; K M Johnston; B A Macleod; M J Walker
Journal:  Br J Pharmacol       Date:  1983-05       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.